首页> 外国专利> New sugar-modified amidine and guanidine compounds, useful as competitive inhibitors of serine protease, e.g. for treating thrombosis

New sugar-modified amidine and guanidine compounds, useful as competitive inhibitors of serine protease, e.g. for treating thrombosis

机译:新的糖修饰的am和胍化合物,可用作丝氨酸蛋白酶的竞争性抑制剂,例如用于治疗血栓形成

摘要

Amidine or guanidine derivatives (I) that include polyhydroxy (cyclo)alkyl groups, their tautomers, stereoisomers, salts and prodrugs. Amidine or guanidine derivatives of formula (I), which include polyhydroxy (cyclo)alkyl groups, their tautomers, stereoisomers, salts and prodrugs are new A-B-D-E-G-K-L (I) A = hydrogen, Me or H-(RA1)iA; RA1 = oxygen-containing heterocyclic residue; iA = 1-20 and if over 1, RA1 are same or different; J = one of the groups RB3-(CH-OH)mB-CH(O)-(CH-OH)lB-(CH-RB2)kB-CH(RB1)-, RB4-(CH-OH)mB-CH(O-)-(CH-OH)nB-CO-, RB4-(CH-OH)mB-CO-CH(O-)-(CH-OH)nB-CO-, or -O-CH2-CO-CH(OH)-(CH-OH)nB-CO-, or A and B together form one of four cyclic groups, or (N-acetyl)neuraminic acid residue, attached through carboxy; RB1 = hydrogen, hydroxymethyl or 1-4C alkyl; RB2 = hydrogen, amino, (acetyl)amino, fluoro or formylamino; RB3 = hydrogen, 1-4C alkyl, 1-4C alkoxymethyl, carboxy, fluoro, acetylamino or aminocarbonyl; RB4 = hydrogen, 1-4C alkyl, 1-4C alkoxymethyl, carboxy or formyl (optionally as acetal); RB5 = hydrogen, 1-4C alkyl, 1-4C alkoxymethyl or carboxy; kB = 0 or 1; lB = 0-3 but not 0 if A, RB1 and RB3 are all hydrogen and D = bond); mB = 0-4; nB = 0-3; D = bond or -N(RD1)-RD2-RD3-RD4-; RD1 = hydrogen or 1-4C alkyl; RD2 = bond or 1-4C alkyl; RD3 = any of 9 cyclic groups; RD4 = bond, 1-4C alkyl, carbonyl, sulfonyl or CH2CO; E = specified aminoalkyl residue; G = any of three 2-carbonyl-N-heterocyclic gropus linked through ring N and the carbonyl, or the group RG3-(CH2)qG-N(-)-CH(CO-)(CH2)rGRG4; qG and rG = 0-2; RG3 and RG4 = hydrogen, 1-6C alkyl, 3-8C cycloalkyl or aryl; K = -NH-(CH2)nK-QK; nK = 0-3; QK = 2-6C alkyl (optionally with up to two CH2 replaced by oxygen or sulfur) or is any of 9 specified heterocyclic residues; L = -C(=NH)-NHRL1 or -NH-C(=NH)-NHRL1; L1 = hydrogen, hydroxy, 1-6C alkoxy, phenyl(CH2)z-O-, 1-6C alkylcarbonyl, 1-6C alkoxycarbonyl or 1-3Calkylaryloxycarbonyl. The full definitions are given in the DEFINITIONS (Full Definitions) Field.
机译:包括多羟基(环)烷基,其互变异构体,立体异构体,盐和前药的或胍衍生物(I)。包括多羟基(环)烷基,其互变异构体,立体异构体,盐和前药的式(I)的或胍衍生物是新的A-B-D-E-G-K-L。 RA 1 =含氧杂环残基; iA = 1-20,如果大于1,则RA <1>相同或不同; J = RB 3-(CH-OH)mB-CH(O)-(CH-OH)lB-(CH-RB 2)kB-CH(RB 1)-中的一个4-(CH-OH)mB-CH(O-)-(CH-OH)nB-CO-,RB 4-(CH-OH)mB-CO-CH(O-)-(CH- OH)nB-CO-或-O-CH2-CO-CH(OH)-(CH-OH)nB-CO-或A和B一起形成四个环状基团之一,或(N-乙酰基)神经氨酸残基,通过羧基连接; RB 1 =氢,羟甲基或1-4C烷基; RB 2 =氢,氨基,(乙酰基)氨基,氟或甲酰基氨基; RB 3 =氢,1-4C烷基,1-4C烷氧基甲基,羧基,氟,乙酰氨基或氨基羰基; RB 4 =氢,1-4C烷基,1-4C烷氧基甲基,羧基或甲酰基(可选地为乙缩醛); RB 5 =氢,1-4C烷基,1-4C烷氧基甲基或羧基; kB = 0或1;如果A,RB 1和RB 3均为氢且D =键,则IB = 0-3,但不为0。 mB = 0-4; nB = 0-3; D =键或-N(RD 1)-RD 2 -RD 3 -RD 4-; RD 1 =氢或1-4C烷基; RD 2 =键或1-4C烷基; RD 3 = 9个环状基团中的任何一个; RD 4 =键,1-4C烷基,羰基,磺酰基或CH 2 CO; E =指定的氨基烷基残基; G =通过环N和羰基连接的三个2-羰基-N-杂环质中的任一个,或基团RG 3-(CH 2)qG-N(-)-CH(CO-)(CH 2)rGRG <4 >; qG和rG = 0-2; RG 3和RG 4 =氢,1-6C烷基,3-8C环烷基或芳基; K = -NH-(CH2)nK-QK; nK = 0-3; QK = 2-6C烷基(可选地最多由两个CH2取代为氧或硫)或为9个指定的杂环残基中的任何一个; L = -C(= NH)-NHRL <1>或-NH-C(= NH)-NHRL <1>; L 1 =氢,羟基,1-6C烷氧基,苯基(CH 2)z -O-,1-6C烷基羰基,1-6C烷氧基羰基或1-3C烷基芳氧基羰基。完整定义在“定义(完整定义)”字段中给出。

著录项

  • 公开/公告号DE10049937A1

    专利类型

  • 公开/公告日2002-04-11

    原文格式PDF

  • 申请/专利权人 KNOLL AG;

    申请/专利号DE2000149937

  • 申请日2000-10-06

  • 分类号C07H7/00;C08B15/00;C08B37/00;C07H15/00;A61K31/155;

  • 国家 DE

  • 入库时间 2022-08-22 00:27:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号